{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:14:36Z","timestamp":1785773676180,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft (DFG)","doi-asserted-by":"publisher","award":["FE785\/2-2"],"award-info":[{"award-number":["FE785\/2-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.antiviral.2016.10.010","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T17:32:35Z","timestamp":1476984755000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Soluble coxsackie- and adenovirus receptor (sCAR-Fc); a highly efficient compound against laboratory and clinical strains of coxsackie-B-virus"],"prefix":"10.1016","volume":"136","author":[{"given":"Sandra","family":"Pinkert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babette","family":"Dieringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Diedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Zeichhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kurreck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.10.010_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00148581-200406010-00001","article-title":"Presentation, diagnosis, and management of enterovirus infections in neonates","volume":"6","author":"Abzug","year":"2004","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.antiviral.2016.10.010_bib2","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis","author":"Abzug","year":"2015","journal-title":"J.\u00a0Pediatr. Infect. Dis. Soc."},{"key":"10.1016\/j.antiviral.2016.10.010_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2015.02.013","article-title":"Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP","volume":"117","author":"Albulescu","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.10.010_bib4","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.10.010_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.antiviral.2015.09.009","article-title":"Molecular mechanism of a specific capsid binder resistance caused by mutations outside the binding pocket","volume":"123","author":"Braun","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.10.010_bib6","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.74.10.4672-4678.2000","article-title":"Octamerization enables soluble CD46 receptor to neutralize measles virus in\u00a0vitro and in\u00a0vivo","volume":"74","author":"Christiansen","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.10.010_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cell.2005.10.035","article-title":"Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions","volume":"124","author":"Coyne","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2016.10.010_bib8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbrc.2006.12.063","article-title":"Anti-enterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles","volume":"353","author":"De Palma","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2016.10.010_bib9","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/AAC.00227-06","article-title":"Enteroviral meningitis: natural history and outcome of pleconaril therapy","volume":"50","author":"Desmond","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.10.010_bib10","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.3390\/molecules16108475","article-title":"Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections","volume":"16","author":"Fechner","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.antiviral.2016.10.010_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature14264","article-title":"AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges","volume":"519","author":"Gardner","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.10.010_bib12","first-page":"12016","article-title":"Inhibition of coxsackie B virus infection by soluble forms of its Receptors: binding affinities, altered particle formation, and competition with cellular receptors","volume":"79","author":"Goodfellow","year":"2005","journal-title":"Society"},{"key":"10.1016\/j.antiviral.2016.10.010_bib13","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1128\/JVI.65.11.6015-6023.1991","article-title":"Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1","volume":"65","author":"Greve","year":"1991","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.10.010_bib14","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/314758","article-title":"Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants","volume":"179","author":"Groarke","year":"1999","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.010_bib15","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1086\/375069","article-title":"Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials","volume":"36","author":"Hayden","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.010_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0928-0197(98)00007-5","article-title":"Enterovirus infections and insulin dependent diabetes mellitus\u2013evidence for causality","volume":"9","author":"Hy\u00f6ty","year":"1998","journal-title":"Clin. Diagn. Virol."},{"key":"10.1016\/j.antiviral.2016.10.010_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/clin.1993.1112","article-title":"Molecular mechanisms in the pathogenesis of enteroviral heart disease: acute and persistent infections","volume":"68","author":"Kandolf","year":"1993","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.antiviral.2016.10.010_bib18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/01.inf.0000237798.07462.32","article-title":"Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983-2003","volume":"25","author":"Khetsuriani","year":"2006","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2016.10.010_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cardiores.2006.05.016","article-title":"Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis","volume":"71","author":"Lim","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.antiviral.2016.10.010_bib20","series-title":"Fields Virology","first-page":"655","article-title":"Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses","author":"Melnick","year":"1996"},{"key":"10.1016\/j.antiviral.2016.10.010_bib21","first-page":"369","article-title":"Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice","volume":"2","author":"Merkle","year":"1999","journal-title":"J.\u00a0Hum. Virol."},{"key":"10.1016\/j.antiviral.2016.10.010_bib22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/JVI.79.1.655-660.2005","article-title":"Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate","volume":"79","author":"Milstone","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.10.010_bib23","first-page":"655","article-title":"Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor ( DAF ), induces a-particle formation in a DAF-binding coxsackievirus B3 isolate","volume":"79","author":"Milstone","year":"2005","journal-title":"Society"},{"key":"10.1016\/j.antiviral.2016.10.010_bib24","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","article-title":"Activity of pleconaril against enteroviruses","volume":"43","author":"Pevear","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.10.010_bib25","doi-asserted-by":"crossref","first-page":"13409","DOI":"10.1128\/JVI.00621-11","article-title":"Virus-host coevolution in a persistently coxsackievirus b3-infected cardiomyocyte cell line","volume":"85","author":"Pinkert","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.10.010_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00315-16","article-title":"The coxsackievirus and adenovirus receptor: glycosylation and the extracellular D2 domain are not required for coxsackievirus B3 infection","author":"Pinkert","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.10.010_bib27","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1161\/CIRCULATIONAHA.108.845339","article-title":"Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor","volume":"120","author":"Pinkert","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.antiviral.2016.10.010_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/gt.2015.19","article-title":"Expression of an engineered soluble coxsackievirus and adenovirus receptor by a dimeric AAV9 vector inhibits adenovirus infection in mice","author":"R\u00f6ger","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.antiviral.2016.10.010_bib29","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dki263","article-title":"Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment","volume":"56","author":"Schmidtke","year":"2005","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2016.10.010_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/viro.2000.0485","article-title":"Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1","volume":"275","author":"Schmidtke","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.10.010_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.antiviral.2008.09.002","article-title":"New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3","volume":"81","author":"Schmidtke","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.10.010_bib32","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1473-3099(02)00277-3","article-title":"FDA panel rejects common cold treatment","volume":"2","author":"Senior","year":"2002","journal-title":"Lancet. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.010_bib33","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1128\/JVI.69.6.3873-3877.1995","article-title":"Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment","volume":"69","author":"Shafren","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.10.010_bib34","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/JVI.02028-06","article-title":"Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication","volume":"81","author":"Si","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.10.010_bib35","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1128\/JVI.77.16.8765-8774.2003","article-title":"Alteration of hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobulin-and mucin-like regions","volume":"77","author":"Silberstein","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.10.010_bib36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/infdis\/jiu504","article-title":"Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice","volume":"211","author":"Stein","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.010_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bcp.2011.08.016","article-title":"Combating enterovirus replication: state-of-the-art on antiviral research","volume":"83","author":"Thibaut","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2016.10.010_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2004.06.006","article-title":"Pleconaril\u2013an advance in the treatment of enteroviral infection in immuno-compromised patients","volume":"32","author":"Webster","year":"2005","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.10.010_bib39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.antiviral.2009.07.002","article-title":"Combination of soluble coxsackievirus-adenovirus receptor and anti-coxsackievirus siRNAs exerts synergistic antiviral activity against coxsackievirus B3","volume":"83","author":"Werk","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.10.010_bib40","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1038\/emi.2014.49","article-title":"Receptors for enterovirus 71","volume":"3","author":"Yamayoshi","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.antiviral.2016.10.010_bib41","first-page":"75","article-title":"Coxsackievirus B3-Associated myocardial pathology and viral load reduced by recombinant soluble human decay-accelerating factor in mice. Lab","volume":"83","author":"Yanagawa","year":"2003","journal-title":"Investig"},{"key":"10.1016\/j.antiviral.2016.10.010_bib42","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1086\/382598","article-title":"Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice","volume":"189","author":"Yanagawa","year":"2004","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.010_bib43","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1128\/JVI.01988-05","article-title":"N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells","volume":"80","author":"Zautner","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.10.010_bib44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00430-003-0198-6","article-title":"Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in\u00a0vitro, virus production in cells, and signs of myocarditis in virus-infected mice","volume":"193","author":"Zell","year":"2004","journal-title":"Med. Microbiol. Immunol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T20:38:30Z","timestamp":1601152710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216303965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":44,"alternative-id":["S0166354216303965"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.10.010","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble coxsackie- and adenovirus receptor (sCAR-Fc); a highly efficient compound against laboratory and clinical strains of coxsackie-B-virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}